Acquisitions was the Most Adopted Growth Strategies by Key Players in the Primary Cells Market

(IT-NEWSWIRE.COM, January 16, 2019 ) According to the new market research report “Primary Cells Market by Type (Human Primary Cells, Animal Primary Cells), Origin (Hematopoietic, Blood, Skin, Gastrointestinal, Hepatocytes, Renal, Skeleton & Muscles), End User (Life Science Research & Research Institutes) - Global Forecast to 2023", published by MarketsandMarkets™, The primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%.

Get 10% Free Customization on this report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32854960
The objectives of this study are as follows:
To define, describe, and forecast the primary cells market by origin, type, end user and region
To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
To identify micromarkets and the drivers, opportunities, and trends affecting the growth of the market
To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
To track and analyze competitive developments such as acquisitions; product launches, expansions; and R&D activities in the primary cells market
Drivers
Increasing cancer research
Primary cells are cells isolated from human or animal tissues. These cells are ideal models for cancer biomarker discovery and drug screening. They are also used to understand the biochemical pathways of cellular interactions.

In cancer research, primary cells are often exposed to heavy radiation doses, chemicals, and viruses, which transforms these cells into cancer cells through genetic mutations and the introduction of oncogenes. In this way, the molecular-level mechanism and cause of cancer, as well as the altered signaling pathways of cancerous cells, can be studied.

Browse and in-depth TOC on “Primary Cells Market”
71 - Tables

35 - Figures

114 - Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/primary-cells-market-32854960.html

North America is expected to command the largest share of the market during the forecast period.

Based on region, the global primary cells market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is estimated to dominate the primary cells market in 2017. This is mainly due to factors such as the increasing research on increasing prevalence of cancer related disorders, and presence of all key players in the region.

Key players in the primary cells market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (US), PromoCell (Germany), ZenBio (US), STEMCELL Technologies (Canada), AllCells (US), American Type Culture Collection (US), and Axol Biosciences (UK).

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=32854960

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/primary-cells-market.asp

Visit Our Website: https://www.marketsandmarkets.com

MarketsandMarkets

Mr. Shelly Singh

1-888-600-6441

sales@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com

Technology News & Search Engine

Acquisitions was the Most Adopted Growth Strategies by Key Players in the Primary Cells Market